Bring the Next Generation
Supplements
to the Market
ENBIOSIS partners with leading pharmaceutical and global health brands to supply clinically-proven, turnkey powder premixes. We go beyond standard supplement manufacturing by using AI to engineer microbiome-driven formulations ready for your production line.
ENBIOSIS offers more than a single product; we provide a scalable R&D pipeline of next generation supplements built on clinical foundations.
Our approach combines clinically supported research, a clear roadmap across disease and wellness areas, and flexible product formats – all designed for efficient scaling through ongoing R&D.
Our first market-ready product, ENBIOSIS Nutra for Dry Eye, serves as the foundation for a broader and expanding pipeline. We supply highly bioavailable, private label health supplements and specialized powder premixes designed for seamless integration into capsules, sachets or functional food bars.
Partnership opportunities
Collaboration models designed to support market expansion, portfolio growth, and long-term value creation.
Premix Supply Partnership
Gain licensing access to our patented nutraceutical formulations and incorporate the microbiome-designed ingredients into your product portfolio.
Licencing Partnership
We work with strategic partners to co-market, license, and expand ENBIOSIS Nutra products through joint commercial initiatives, private-label opportunities, and shared go-to-market strategies.
Health brands we collaborate with
Pharmaceutical & biotechnology companies
Partner with ENBIOSIS to expand your portfolio with science-backed, microbiome-driven health solutions.
Food & functional nutrition companies
Integrate AI-designed microbiome science into functional products of next-generation supplements.
Ingredient & supplier companies
Apply AI & microbiome intelligence to elevate innovation and unlock new application opportunities.
A platform built for scale
ENBIOSIS products are developed with global scalability in mind, from formulation and manufacturing to regulatory and commercialization pathways.
Our pipeline continues to expand across multiple microbiome-linked indications, creating ongoing opportunities for partners to grow alongside the platform.
Become a Partner
Get in touch with us if you are interested in distributing, collaborating, or exploring strategic opportunities with ENBIOSIS.
Let’s build the future of microbiome-driven health, together.